Mahtab Moayeri Selected Research

raxibacumab

1/2021	A Review of the Efficacy of FDA-Approved B. anthracis Anti-Toxin Agents When Combined with Antibiotic or Hemodynamic Support in Infection- or Toxin-Challenged Preclinical Models.
12/2015	Raxibacumab augments hemodynamic support and improves outcomes during shock with B. anthracis edema toxin alone or together with lethal toxin in canines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mahtab Moayeri Research Topics

Disease

63	Anthrax 01/2022 - 02/2002
23	Edema (Dropsy) 01/2022 - 11/2005
19	Infections 01/2021 - 05/2003
7	Shock 01/2021 - 02/2004
3	Inflammation (Inflammations) 01/2018 - 03/2006
3	Peritonitis 01/2016 - 01/2014
3	Neoplasms (Cancer) 03/2013 - 01/2008
2	Hypoxia (Hypoxemia) 01/2021 - 09/2003
2	Hypotension (Low Blood Pressure) 11/2017 - 01/2016
2	Gout 01/2016 - 03/2015
2	Melanoma (Melanoma, Malignant) 01/2016 - 01/2008
2	Sepsis (Septicemia) 06/2007 - 02/2005
1	Pain (Aches) 01/2022
1	Septic Shock (Toxic Shock Syndrome) 01/2021
1	Plague (Bubonic Plague) 10/2018
1	Tuberculosis (Tuberculoses) 09/2015
1	Pulmonary Tuberculosis 09/2015
1	Bacterial Infections (Bacterial Infection) 06/2014
1	Toxoplasmosis 02/2014
1	Disease Progression 11/2011

Drug/Important Bio-Agent (IBA)

20	AntigensIBA 01/2022 - 02/2005
17	InflammasomesIBA 12/2020 - 02/2008
16	anthrax toxin (anthrax lethal factor)IBA 01/2022 - 02/2002
13	Virulence Factors (Pathogenicity Factors)IBA 01/2015 - 09/2003
10	edema factorIBA 01/2022 - 08/2009
9	Monoclonal AntibodiesIBA 09/2013 - 02/2005
7	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2002
6	Peptide Hydrolases (Proteases)FDA Link 01/2020 - 05/2010
5	Adenylyl Cyclases (Adenylyl Cyclase)IBA 01/2021 - 11/2005
5	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 10/2005
3	Bacterial ToxinsIBA 01/2022 - 05/2003
3	adefovirIBA 01/2021 - 03/2011
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2020 - 01/2008
3	Peptides (Polypeptides)IBA 01/2016 - 08/2006
2	raxibacumabIBA 01/2021 - 12/2015
2	VaccinesIBA 10/2018 - 12/2005
2	Plague VaccineIBA 10/2018 - 01/2017
2	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 11/2017 - 01/2016
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 10/2017 - 04/2009
2	Saline SolutionIBA 10/2017 - 06/2007
2	Single-Domain AntibodiesIBA 10/2016 - 03/2015
2	AntibodiesIBA 01/2016 - 03/2015
2	EpitopesIBA 01/2016 - 01/2011
2	NucleotidesIBA 01/2016 - 02/2014
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2016 - 04/2004
2	Matrix Metalloproteinases (MMPs)IBA 09/2015 - 01/2008
2	Uric Acid (Urate)IBA 03/2015 - 01/2014
2	Capsules (Microcapsules)IBA 01/2015 - 01/2011
2	ExotoxinsIBA 06/2014 - 09/2013
2	Caspase 1 (ICE Protease)IBA 02/2014 - 12/2010
2	FlagellinIBA 01/2014 - 10/2012
2	Calmodulin (Calcium-Dependent Activator Protein)IBA 01/2013 - 08/2009
2	Proteasome Endopeptidase Complex (Proteasome)IBA 12/2008 - 02/2008
2	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 06/2004 - 05/2003
2	CytokinesIBA 04/2004 - 02/2004
1	Neutralizing AntibodiesIBA 01/2022
1	Formaldehyde (Formol)FDA Link 01/2022
1	Botulinum Toxins (Botulinum Toxin)IBA 01/2022
1	CarrageenanIBA 01/2022
1	Anthrax Immune Globulin IntravenousIBA 01/2021
1	obiltoxaximabIBA 01/2021
1	AntitoxinsIBA 01/2021
1	Phosphotransferases (Kinase)IBA 12/2020
1	Combined VaccinesIBA 10/2018
1	BiothraxIBA 10/2018
1	Biological Warfare AgentsIBA 10/2018
1	NanovaccinesIBA 10/2018
1	Capsid Proteins (Capsid Protein)IBA 10/2018
1	Subunit VaccinesIBA 10/2018
1	CathepsinsIBA 01/2018
1	Cathepsin BIBA 01/2018
1	Immunoglobulins (Immunoglobulin)IBA 10/2017
1	sulforaphaneIBA 01/2016
1	leucine receptorIBA 01/2016
1	Heme Oxygenase-1IBA 09/2015
1	Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA 09/2015
1	15-deoxyprostaglandin J2IBA 03/2015
1	Leucine (L-Leucine)FDA Link 02/2014
1	Interleukin-18 (Interleukin 18)IBA 02/2014
1	NigericinIBA 01/2014
1	sodium arsenite (sodium metaarsenite)IBA 01/2014
1	Arsenicals (Arsenic Compounds)IBA 01/2014
1	Arsenic Trioxide (Trisenox)FDA Link 01/2014
1	Adenosine Monophosphate (AMP)IBA 01/2013
1	Adenosine Triphosphate (ATP)IBA 01/2013
1	Claudin-5IBA 01/2013
1	EnzymesIBA 10/2012
1	LipidsIBA 10/2012
1	ProstaglandinsIBA 10/2012
1	LeukotrienesIBA 10/2012
1	EicosanoidsIBA 10/2012
1	Cyclooxygenase 1IBA 10/2012
1	NLR ProteinsIBA 01/2012
1	ElementsIBA 11/2011
1	Auranofin (Ridaura)FDA Link 03/2011
1	Dobutamine FDA LinkGeneric 03/2011

Therapy/Procedure

13	Therapeutics 01/2022 - 02/2002
1	Analgesia 01/2022
1	Controlled Hypotension 11/2017
1	Treatment Delay 06/2011